More Stories

Informist, Tuesday, Jul. 28, 2026

MUMBAI - Specialty chemical company PCBL Chemical Ltd. is expected to report strong revenue growth for the June quarter, supported by higher carbon black realisations and volume growth, according to brokerages tracking the company. The company's net profit is, however, expected to decline due to lower margins in the carbon black business and continued weak performance by subsidiary Aquapharm Chemical Ltd.

The company is expected to report a consolidated net profit of between INR 681 million and INR 961 million, according to the estimates from three brokerages. The net profit is seen declining 13% from INR 930.9 million for the year-ago quarter but is expected to nearly double from the INR 470.2 million reported for the March quarter.

PCBL's net sales for the June quarter are seen between INR 21.78 billion and INR 24.27 billion, according to the estimates. This will be sharply up from INR 14.53 billion reported in the year-ago quarter and from INR 13.71 billion reported in the March quarter.

The highest estimate for the company's June-quarter net profit is INR 961 million from 360 ONE Capital Market Pvt. Ltd., while the lowest estimate is INR 681 million from ICICI Securities Ltd. The highest estimate for PCBL's net sales is INR 24.26 billion from ICICI Securities, while the lowest estimate is INR 21.78 billion from 360 ONE.

PCBL is expected to perform in line with other specialty chemical companies, brokerages said. The carbon black maker is expected to report healthy revenue growth in the June quarter on account of higher realisations, following the pass-through of input costs, ICICI Securities said.

The company's carbon black volumes are likely to rise 8% on year supported by improved exports after the removal of US tariffs and healthy domestic demand, brokerages said. The company's gross profit per kilogram from carbon black is expected to decline 4.2% on year.

PCBL Chemical's earnings before interest, tax, depreciation, and amortisation for the June quarter are expected in a range of INR 2.74 billion and INR 2.85 billion, according to two brokerage estimates. The highest estimate is INR 2.85 billion from SMIFS Ltd. while the lowest estimate is INR 2.74 billion from ICICI Securities.

Aquapharm is likely to report an EBITDA loss and negative margin due to subdued pricing and lower volumes, brokerages said. Meanwhile, PCBL's lower raw material costs are expected to expand its margins for the June quarter, SMIFS said.

PCBL Chemical is expected to announce its June quarter earnings Wednesday. Tuesday, shares of PCBL closed at INR 318.40 on the National Stock Exchange, down more than 2% from Monday. The stock is up more than 9% since the company reported its March quarter earnings on April 30.

Of the seven brokerage reports on the company available with Informist, one has a "buy" recommendation on the stock with a target price of INR 440 per share, which is 38% higher than the stock's closing price Tuesday. Four brokerage have a "hold" call with a target price of INR 303, while two brokerages have a "sell" recommendation with a target price of INR 288. 
 

Following are the Apr-Jun earnings estimates for PCBL Chemical Ltd. from three brokerages in the descending order of the estimate of net profit, in INR million:
 

End

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

Edited by

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

Informist Media Tel +91 (22) 6985-4000
 

Send comments to feedback@informistmedia.com

© Informist Media Pvt. Ltd. 2026. All rights reserved.

End

Reported by Rosalin Lenka

Edited by Pankaj Aher

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

Informist Media Tel +91 (22) 6985-4000 /+91 (11) 4220-1000

Send comments to feedback@informistmedia.com

© Informist Media Pvt. Ltd. 2026. All rights reserved.